NASDAQ: HLXBHelix Acquisition Corp II Stock
$10.75+0.00 (+0%)
Updated Mar 18, 2025
HLXB Price
$10.75
Fair Value Price
N/A
Market Cap
$252.72M
52 Week Low
$10.14
52 Week High
$11.59
P/E
29.86x
P/B
-67.71x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
$7.60M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-1.53
Operating Cash Flow
-$764k
Beta
0.06
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
HLXB Overview
Helix Acquisition Corp. II focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Boston, Massachusetts.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine HLXB's potential to beat the market
- HLXB doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Shell Company
Industry Rating
F
HLXB
RankedUnranked of 9
RankedUnranked of 9
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $9.84 | C | |
| $10.14 | C | |
| $10.05 | C |
Be the first to know about important HLXB news, forecast changes, insider trades & much more!
HLXB News
Overview
Due Diligence Score
–
Industry Average (7)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how HLXB scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
HLXB is good value based on its earnings relative to its share price (29.86x), compared to the US market average (30.9x)
P/E vs Market Valuation
HLXB is poor value based on its earnings relative to its share price (29.86x), compared to the US Shell Companies industry average (16.8x)
P/E vs Industry Valuation
HLXB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more HLXB due diligence checks available for Premium users.
Valuation
HLXB price to earnings (PE)
For valuing profitable companies with steady earnings
Company
29.86x
Industry
16.8x
Market
30.9x
HLXB is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
HLXB is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
HLXB price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-67.71x
Industry
-44.21x
HLXB's financial health
Profit margin
Revenue
$0.0
Net Income
$2.0M
Profit Margin
0%
HLXB's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$194.4M
Liabilities
$5.7M
Debt to equity
-1.53
HLXB's short-term assets ($1.95M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HLXB's long-term liabilities ($5.52M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HLXB's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
HLXB's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$87.9k
Investing
$0.0
Financing
$0.0
HLXB's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
HLXB vs Shell Company Stocks
Helix Acquisition II Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.